A quantitative IHC analysis indicated a non-significant trend of decreased total retinal LRP-1 immunoreactivity in AD compared to CN controls (Fig. 6e), with no difference between levels of LRP-1 in MCI vs. CN controls. Here, LRP1 is linked to Alzheimer disease.